Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02) [Phase 1]

View source ↗

Summary

This clinical trial update reports an ongoing Phase 1 study evaluating datopotamab deruxtecan in combination with pembrolizumab, with or without platinum-based …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Datopotamab Deruxtecan (datopotamab deruxtecan)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced or Metastatic NSCLC | Phase 1 | Status: ACTIVE_NOT_RECRUITING